2018 / 06

Next Paper
DOI: 10.24075/brsmu.2018.094
Copyright: © 2019 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

OPINION

The use of monoclonal antibodies in autoimmunity treatment

Merzlyak EM1,2, Syrko DS2, Musatkina EA2, Israelson MA1,2
About authors

1 Group of structural Organization of T-cell Immunity, Department of Adaptive Immunity Genomics, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow

2 Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow

Correspondence should be addressed: Ekaterina M. Merzlyak
Miklouho-Maclay 16/10, Moscow, 117997; ur.liam@99niretake

About paper

Funding: this work was supported by the Ministry of Science and Higher Education of the Russian Federation (ID RFMEFI60716X0158).

Received: 2018-12-06 Accepted: 2018-12-27 Published online: 2019-01-01
|
Figure. Monoclonal antibody treatment approaches for autoimmune disorders